SEC
SlamSEC
SearchBrowseEarnings

SELLAS Life Sciences Group, Inc.

Nasdaq:SLS
Pharmaceutical Preparations·NEW YORK, NY
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(1000 total)

TypeDateAccessionPeriodSize
SCHEDULE 13G/A
Feb 17, 2026
0001193125-26-053508
—
33.2 KB
SCHEDULE 13G/A
Jan 30, 2026
0000902664-26-000615
—
10.3 KB
4
Jan 9, 2026
0001104659-26-002515OWNERSHIP DOCUMENT
Jan 7, 2026
5.1 KB
4
Jan 9, 2026
0001104659-26-002511OWNERSHIP DOCUMENT
Jan 7, 2026
5.2 KB
4
Jan 9, 2026
0001104659-26-002509OWNERSHIP DOCUMENT
Jan 7, 2026
5.1 KB
4
Jan 9, 2026
0001104659-26-002506OWNERSHIP DOCUMENT
Jan 7, 2026
5.3 KB
4
Jan 9, 2026
0001104659-26-002502OWNERSHIP DOCUMENT
Jan 7, 2026
5.2 KB
4
Jan 9, 2026
0001104659-26-002499OWNERSHIP DOCUMENT
Jan 7, 2026
5.1 KB
4
Jan 9, 2026
0001104659-26-002491OWNERSHIP DOCUMENT
Jan 7, 2026
5.2 KB
8-K
Jan 8, 2026
0001104659-26-001957FORM 8-K
Jan 7, 2026
188.3 KB
4
Dec 5, 2025
0001104659-25-118882OWNERSHIP DOCUMENT
Dec 3, 2025
5.5 KB
4
Dec 5, 2025
0001104659-25-118878OWNERSHIP DOCUMENT
Dec 3, 2025
5.4 KB
4
Dec 5, 2025
0001104659-25-118872OWNERSHIP DOCUMENT
Dec 3, 2025
5.6 KB
EFFECT
Nov 25, 2025
9999999995-25-003386
—
2.0 KB
CORRESP
Nov 21, 2025
0001104659-25-114977
—
8.3 KB
4
Nov 21, 2025
0001104659-25-114806OWNERSHIP DOCUMENT
Nov 19, 2025
5.3 KB
SCHEDULE 13G
Nov 14, 2025
0001193125-25-282690
—
32.6 KB
8-K
Nov 12, 2025
0001390478-25-0000218-K
Nov 12, 2025
228.2 KB
10-Q
Nov 12, 2025
0001390478-25-00002010-Q
Sep 30, 2025
4.2 MB
424B5
Oct 27, 2025
0001104659-25-102602424B5
—
499.2 KB
8-K
Oct 27, 2025
0001104659-25-102345FORM 8-K
Oct 24, 2025
432.3 KB
SCHEDULE 13G
Oct 17, 2025
0002012383-25-002700
—
10.8 KB
S-3
Oct 10, 2025
0001104659-25-098711FORM S-3
—
359.7 KB
8-K
Oct 3, 2025
0001104659-25-096643FORM 8-K
Oct 1, 2025
211.3 KB
8-K
Sep 11, 2025
0001104659-25-089272FORM 8-K
Sep 10, 2025
409.4 KB
25 filings shown
CFO
Burns John Thomas